Asymmetric dimethylarginine and oxidative stress following coronary artery bypass grafting: associations with postoperative outcome

Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion

(2011) Nihat Sen et al.   ATHEROSCLEROSIS

Effects of coronary revascularization with or without cardiopulmonary bypass on plasma levels of asymmetric dimethylarginine

(2011) Attila Cziráki et al.   CORONARY ARTERY DISEASE

Inflammatory/oxidative stress during the first week after different types of cardiac surgery

(2010) Inga Karu et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL

Association between plasma asymmetrical dimethylarginine activity and saphenous vein graft disease in patients with coronary bypass

(2009) Goksel Cagirci et al.   CORONARY ARTERY DISEASE

Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis

(2009) C. Antoniades et al.   EUROPEAN HEART JOURNAL

Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality—An update on patient populations with a wide range of cardiovascular risk

(2009) Rainer H. Böger et al.   PHARMACOLOGICAL RESEARCH